Form 4: Cognition Therapeutics CEO Lisa Ricciardi Increases Stake in Company
SEC Form 4
CEO Lisa Ricciardi purchased 5,700 shares of Cognition Therapeutics (CGTX) at $1.75 per share on March 14, 2024, increasing her direct holdings to 291,345 shares.
Summary
- On March 14, 2024, Lisa Ricciardi, CEO and President of Cognition Therapeutics Inc. (CGTX), acquired 5,700 shares of common stock.
- The purchase price was $1.75 per share.
- This transaction increased Ricciardi's direct ownership to 291,345 shares of Cognition Therapeutics Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the purchase is relatively small and doesn't provide a strong signal.
Positives
- The CEO's purchase of company stock may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of transaction: Lisa Ricciardi purchased 5,700 shares of CGTX. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.